Polymorphonuclear leukocyte apoptosis is inhibited by platelet-released mediators, role of TGFβ-1

Thrombosis and Haemostasis

Volumn 84, Issue 3, 2000, Pages 478-483

  Brunetti, M ^a   Martelli, N ^a   Manarini, S ^a   Mascetra, N ^a   Musiani, P ^a   Cerletti, C ^a   Aiello, F B ^a   Evangelista, V ^a  

^a Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

Apoptosis; Human; Inflammation; Neutrophils; Platelets

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYTOKINE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY; THROMBIN; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN INDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0033832169     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614048     Document Type: Article

References (57)

1. Roles for human platelets in inflammation
2. Bidirectional modulation of platelet and polymorphonuclear leukocyte activities
3. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: Role of PSGL-1 as a signaling molecule
4. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes
5. Sequential potentiation and inhibition of PMN reactivity by maximally stimulated platelets
6. Platelets in inflammatory glomerular injury
7. The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction
8. Neutrophil depletion suppresses 111in-labeled platelet accumulation in infarcted myocardium
9. Proteinases and cytokines in neutrophil and platelet interactions in vitro. Possible relevance to the adult respiratory distress syndrome
10. Number and activation of circulating polymorphonuclear leukocytes and platelets are associated with neonatal respiratory distress syndrome severity
11. Platelet function in septic multiple organ dysfunction syndrome
12. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure
13. Inhibition of human neutrophil apoptosis by platelets
14. Apoptosis of neutrophils
15. Apoptosis in resolution of inflammation
16. Impairment of function in aging neutrophils is associated with apoptosis
17. The use of prostacyclin in the separation from plasma and washing of human platelets
18. Activated platelets express IL-1 activity
19. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production
20. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event
21. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells
22. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
23. Mcl-1 expression in human neutrophils: Regulation by cytokines and correlation with cell survival
24. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1
25. 1,25-dihydroxyvitamin D3, transforming growth factor beta1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes
26. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells
27. Involvement of u-PA in the anti-apoptotic activity of TGFbeta for vascular smooth muscle cells
28. Transforming growth factor-betas in neurodegenerative disease
29. Latent transforming growth factor-beta: Structural features and mechanisms of activation
30. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils
31. p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils
32. The search for physiological substrates of MAP and SAP kinases in mammalian cells
33. Structural requirements of platelet chemokines for neutrophil activation
34. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization
35. Type beta transforming growth factor in human platelets: Release during platelet degranulation and action on vascular smooth muscle cells
36. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences
37. Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization
38. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin
39. Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells
40. Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: Proposed mechanism of inhibition of IL-1 action
41. Transforming growth factor-beta inhibition of interleukin-1 activity involves down-regulation of interleukin-1 receptors on chondrocytes
42. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death
43. Enhancement of human neutrophil survival and activation by TGF-beta 1
44. Transforming growth factor-beta increases the inhibitory effects of GM-CSF and dexamethasone on neutrophil apoptosis
45. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides
46. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system
47. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1
48. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism
49. Thrombospondin-1 is a major activator of TGF-beta1 in vivo
50. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3
51. Inhibition of kinases impairs neutrophil activation and killing of Staphylococcus aureus
52. Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst
53. Interleukin-1
54. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF
55. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation
56. Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists
57. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide